group 1 - Charcot Marie Tooth type 1A - Silencing of PMP22 promoter 2 using a CRISPR/dCas9 combined with methyltransferase (DNMT3A)

group 2 - A Leap Back in Time:Lentiviral Vector-Mediated Expression of WRN Gene in Werner Syndrome

group 3 - OTRS-en-CRISPRi: A novel therapeutic approach in Anaplastic Thyroid Cancer treatment

group 4 - RACGAP1 competitive inhibition in hepatocellular carcinoma via Onyx-015 mRNA transfection

Gruppo B - Rescue of immunodeficiency in patients with Bloom syndrome through AAV9

GENE THERAPY FOR THE Silencing OF THE EXPRESSION OF THE FTL498InsTC GENE IN Mice models WITH IRON ACCUMULATION IN THE striatum AND MOTOR CORTEX

iRNA FOR THE CONTROL OF NEUROINFLAMMATION IN ALZHEIMER'S DISEASE

A new approach against Breast Cancer: Reversion of mutation at exon 11 of BRCA1 using Prime editing and a modified Adenovirus

FGFR3-TACC3 GENE FUSION IN HUMAN GLIOMA:A NEW COMBINED GENE THERAPY APPROACHUSING CAS13A AND A GFAP-SELECTIVEONCOLYTIC ADENOVIRUS

Defeating Non-Small Cell Lung Cancer Using TanCAR-T cells targeting B7-H3 and EGFR: A New Era of Hope

INTERACTION AMBRA1- c-MYC  IN GROUP3 OF MEDULLOBLASTOMA

A novel combination therapy: NF2 gene addition and bevacizumab in vestibular schwannoma

Abdollahzadeh M

BARRIOS GUTIÉRREZ V

BENSOUNA I

Brebel B

PREVIDI A

CAREL I

Ghazelian H

GUILLAUME H

KANE CHARVIN M

PEREIRA L

POUTIER B

PUJOLAR RAMOS

REICH M

THOMAS E

TOGNON A

A. Eon

E. Lebail

C. Blanc

G. Giraud

A. Delamarre

S. Rose

R. Rubiu

Z. Mars

2018/2019 poster competition winner

Progetto 2011: Terapia genica displasia fibrosa. di Papacci, Mariano, Proietto, Pecce

Progetto 2011: Terapia genica HGPS di Legnini, Lenzi, Maiello, Stipo, Tita